Please complete the form below to receive relevant information from Incyte, such as further
information on ICLUSIG® and treatment of chronic myeloid leukaemia (CML)
Adverse events should be reported. Reporting forms and information can be found at
www.hpra.ie.
Adverse events should also be reported to Incyte immediately by phoning the Toll-free phone number
1800-456-748.
You are now leaving the Incyte Iclusig website. This link will take you to a site that is not
owned or maintained by Incyte. Incyte is not responsible for the information contained on
third-party sites
You are now leaving the site www.iclusig.ie.
This link will take you to a site https://www.incyte.com, owned by Incyte Corporation and managed
by the company.